117 related articles for article (PubMed ID: 12270157)
1. A multidetachable sulfamate linker successfully used in a solid-phase strategy to generate libraries of sulfamate and phenol derivatives.
Poirier D; Ciobanu LC; Bérubé M
Bioorg Med Chem Lett; 2002 Oct; 12(20):2833-8. PubMed ID: 12270157
[TBL] [Abstract][Full Text] [Related]
2. Solid-phase parallel synthesis of 17alpha-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker.
Ciobanu LC; Poirier D
J Comb Chem; 2003; 5(4):429-40. PubMed ID: 12857111
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of libraries of 16beta-aminopropyl estradiol derivatives for targeting two key steroidogenic enzymes.
Ciobanu LC; Poirier D
ChemMedChem; 2006 Nov; 1(11):1249-59. PubMed ID: 16986200
[TBL] [Abstract][Full Text] [Related]
4. Preparation of 6beta-estradiol derivative libraries as bisubstrate inhibitors of 7beta-hydroxysteroid dehydrogenase type using the multidetachable sulfamate linker.
Bérubé M; Delagoutte F; Poirier D
Molecules; 2010 Mar; 15(3):1590-631. PubMed ID: 20336003
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of aryl sulfamate and phenol small peptide derivatives using a multidetachable sulfamate linker strategy.
Fournier D; Breuil PA; Poirier D
Adv Exp Med Biol; 2009; 611():219-20. PubMed ID: 19400168
[No Abstract] [Full Text] [Related]
6. Solid-phase organic synthesis (SPOS) of modulators of estrogenic and androgenic action.
Poirier D; Maltais R
Mini Rev Med Chem; 2006 Jan; 6(1):37-52. PubMed ID: 16457631
[TBL] [Abstract][Full Text] [Related]
7. Focused libraries of 16-substituted estrone derivatives and modified e-ring steroids: inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Vicker N; Lawrence HR; Allan GM; Bubert C; Smith A; Tutill HJ; Purohit A; Day JM; Mahon MF; Reed MJ; Potter BV
ChemMedChem; 2006 Apr; 1(4):464-81. PubMed ID: 16892382
[TBL] [Abstract][Full Text] [Related]
8. Solid-phase synthesis of phenolic steroids: from optimization studies to a convenient procedure for combinatorial synthesis of biologically relevant estradiol derivatives.
Tremblay MR; Poirier D
J Comb Chem; 2000; 2(1):48-65. PubMed ID: 10750486
[TBL] [Abstract][Full Text] [Related]
9. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
10. Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
Shah R; Singh J; Singh D; Jaggi AS; Singh N
Eur J Med Chem; 2016 May; 114():170-90. PubMed ID: 26974384
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship determination within a group of substituted phenyl sulfamate based compounds against the enzyme oestrone sulfatase.
Patel CK; Galisson A; James K; Owen CP; Ahmed S
J Pharm Pharmacol; 2003 Feb; 55(2):211-8. PubMed ID: 12631414
[TBL] [Abstract][Full Text] [Related]
12. Aryl sulfamates are broad spectrum inactivators of sulfatases: effects on sulfatases from various sources.
Bojarová P; Williams SJ
Bioorg Med Chem Lett; 2009 Jan; 19(2):477-80. PubMed ID: 19058962
[TBL] [Abstract][Full Text] [Related]
13. Novel sulfamate derivatives of menthol: Synthesis, characterization, and cholinesterases and carbonic anhydrase enzymes inhibition properties.
Daryadel S; Atmaca U; Taslimi P; Gülçin İ; Çelik M
Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800209. PubMed ID: 30255953
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and sulfatase inhibitory activities of (E)- and (Z)-4-hydroxytamoxifen sulfamates.
Chu GH; Peters A; Selcer KW; Li PK
Bioorg Med Chem Lett; 1999 Jan; 9(2):141-4. PubMed ID: 10021916
[TBL] [Abstract][Full Text] [Related]
15. Sulfamates and their therapeutic potential.
Winum JY; Scozzafava A; Montero JL; Supuran CT
Med Res Rev; 2005 Mar; 25(2):186-228. PubMed ID: 15478125
[TBL] [Abstract][Full Text] [Related]
16. Efficacious N-protection of O-aryl sulfamates with 2,4-dimethoxybenzyl groups.
Reuillon T; Bertoli A; Griffin RJ; Miller DC; Golding BT
Org Biomol Chem; 2012 Oct; 10(37):7610-7. PubMed ID: 22893112
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates.
Newman SP; Leese MP; Purohit A; James DR; Rennie CE; Potter BV; Reed MJ
Int J Cancer; 2004 Apr; 109(4):533-40. PubMed ID: 14991574
[TBL] [Abstract][Full Text] [Related]
18. 17Beta-hydroxy-11alpha-(3'-sulfanylpropyl)oxy-estra-1,3,5(10)- trien-3-yl sulfamate--a novel hapten structure: toward the development of a specific enzyme immunoassay (EIA) for estra-1,3,5(10)-triene-3-yl sulfamates.
Schwarz S; Schumacher M; Ring S; Nanninga A; Weber G; Thieme I; Undeutsch B; Elger W
Steroids; 1999 Jul; 64(7):460-71. PubMed ID: 10443902
[TBL] [Abstract][Full Text] [Related]
19. Acid dissociation constant, a potential physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
Ahmed S; Owen CP; James K; Patel CK; Patel M
Bioorg Med Chem Lett; 2001 Apr; 11(7):899-902. PubMed ID: 11294387
[TBL] [Abstract][Full Text] [Related]
20. The sulfamate functional group as a new anchor for solid-phase organic synthesis.
Ciobanu LC; Maltais R; Poirier D
Org Lett; 2000 Feb; 2(4):445-8. PubMed ID: 10814347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
